EIBIR Winter School on Interdisciplinary Biomedical Imaging

17-22 January 2010, Viladrau, Spain.
The main objective of the EIBIR Winter School is to support the interdisciplinary training of technical and clinical PhD students working in the broad area of biomedical imaging. In this first EIBIR Winter School on Interdisciplinary Biomedical Imaging, two key clinical disease areas will be addressed which altogether represent the two leading causes of death worldwide: cardiovascular and oncologic diseases. Each topic will be covered from the perspective of novel methods for biomedical image acquisition, analysis and interpretation as well as from the perspective of computational modeling and interventional planning, where appropriate. The themes will be explored based on the key driving clinical questions as well as from an understanding of the underlying disease mechanisms or pathophysiology.

The faculty will include lecturers with a clinical, biomedical and technical background, from both academia and industry. Reading groups, poster sessions and social activities will be offered.

Target Group
Second- and third-year students pursuing their graduate studies within PhD programs of biomedical engineering, computer science, electrical engineering, physics, medical physics, and medicine. Participants should have a basic understanding of biomedical imaging in terms of acquisition and image analysis and interpretation. Possibility to earn CME credits.

Location
Viladrau/Spain, about 70km from Barcelona, located within the Montseny Natural Park

Application
Via email to This email address is being protected from spambots. You need JavaScript enabled to view it., until October 22nd, 2009 including:

  • Curriculum Vitae including contact details of two referees and current main supervisor
  • Letter of intention
Number of participants admitted: 45 PhD students;

Notification of selected candidates: Before November 15th 2009

Participation fees
EUR 645,- (twin room)
EUR 795,- (single room)
Including attendance of the course, full board accommodation, bus from Barcelona to Viladrau and back, all social activities. Payment of registration fees before December 1st, 2009.

For further information, please visit:
http://www.eibir.org

About EIBIR
The European Institute for Biomedical Imaging Research (EIBIR) is a non-profit limited liability company that was founded in 2006 by the European Society of Radiology (ESR), dedicated to the co-ordination of research.

EIBIR has the aim of co-ordinating and supporting the development of biomedical imaging technologies and the dissemination of knowledge with the ultimate goal of improving diagnosis, treatment and prevention of disease.

The platform supports networking activities in research and is key to spreading good practice, promoting common initiatives and interoperability in the field of biomedical imaging research.

Most Popular Now

AI Catches One-Third of Interval Breast …

An AI algorithm for breast cancer screening has potential to enhance the performance of digital breast tomosynthesis (DBT), reducing interval cancers by up to one-third, according to a study published...

NHS National Rehabilitation Centre to De…

The new NHS National Rehabilitation Centre will deploy technology to help patients to maintain their independence as they recover from life-changing injuries and illnesses and regain quality of life. Airwave Healthcare...

AI Finds Hundreds of Potential Antibioti…

Snake, scorpion, and spider venom are most frequently associated with poisonous bites, but with the help of artificial intelligence, they might be able to help fight antibiotic resistance, which contributes...

Meet Your Digital Twin

Before an important meeting or when a big decision needs to be made, we often mentally run through various scenarios before settling on the best course of action. But when...

AI Tool Accurately Detects Tumor Locatio…

An AI model trained to detect abnormalities on breast MR images accurately depicted tumor locations and outperformed benchmark models when tested in three different groups, according to a study published...

AI can Accelerate Search for More Effect…

Scientists have used an AI model to reassess the results of a completed clinical trial for an Alzheimer’s disease drug. They found the drug slowed cognitive decline by 46% in...

AI Accurately Classifies Pancreatic Cyst…

Artificial intelligence (AI) models such as ChatGPT are designed to rapidly process data. Using the AI ChatGPT-4 platform to extract and analyze specific data points from the Magnetic Resonance Imaging...

Free AI Tools can Help Doctors Read Medi…

A new study from the University of Colorado Anschutz Medical Campus shows that free, open-source artificial intelligence (AI) tools can help doctors report medical scans just as well as more...

Great plan: Now We need to Get Real abou…

The government's big plan for the 10 Year Health Plan for the NHS laid out a big role for delivery. However, the Highland Marketing advisory board felt the missing implementation...

Autonomous AI Agents in Healthcare

The use of large language models (LLMs) and other forms of generative AI (GenAI) in healthcare has surged in recent years, and many of these technologies are already applied in...

Can Amazon Alexa or Google Home Help Det…

Computer scientists at the University of Rochester have developed an AI-powered, speech-based screening tool that can help people assess whether they are showing signs of Parkinson’s disease, the fastest growing...

Researchers Create 'Virtual Scienti…

There may be a new artificial intelligence-driven tool to turbocharge scientific discovery: virtual labs. Modeled after a well-established Stanford School of Medicine research group, the virtual lab is complete with an...